VYNE
VYNE Therapeutics Inc.Company with tickers: VYNE
CIK
1566044
CUSIP
92941V308
Shares Outstanding
33,352,858
Website
https://www.vynetherapeutics.com
13F Activity (30d)
3 filings
2 filers
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Capacity | Remaining | As of | Runs Through | Source |
|---|---|---|---|---|---|
| 2024-03-01 | $50,000,000 | — | — | — | 10-Q , filed 2026-05-15 |